STARLIMS

STARLIMS is a global provider of laboratory information management systems (LIMS) serving over 700 customers and 2,000+ laboratories across 85+ countries. Founded in 1986 by Itschak Friedman and Dinu Toiba as StarLIMS Technologies, the company has evolved through multiple ownership transitions.

The company was acquired by Abbott in 2009 for $123 million, rebranded as Abbott Informatics in 2014, and subsequently sold to private equity firm Francisco Partners in July 2021. STARLIMS now operates as a privately-held company with 270 full-time employees (201-500 range) headquartered in Hollywood, Florida.

STARLIMS serves pharmaceutical, biotechnology, CDMO, clinical diagnostics, food & beverage, chemicals, oil & gas, and environmental testing laboratories. STARLIMS offers broad regulatory compliance capabilities including FDA 21 CFR Part 11, EU Annex 11, ISO 17025, ISO 9001:2015, ISO 27001:2022, cGXP, ASCLD-LAB, and CALEA.

With 35+ years of LIMS experience and global deployment scale, STARLIMS positions itself as an enterprise-grade laboratory data management platform integrating LIMS, ELN (Labstep), SDMS, LES, and advanced analytics capabilities.

STARLIMS is a multi-industry LIMS vendor serving pharmaceutical, biotechnology, CDMO, clinical diagnostics, food & beverage, chemicals, oil & gas, and environmental testing laboratories. STARLIMS positions itself as a comprehensive laboratory data management platform capable of serving diverse regulatory environments.

The company serves 700+ customers globally across pharmaceutical and non-pharma sectors. Pharmaceutical customers benefit from built-in FDA 21 CFR Part 11, EU Annex 11, and cGXP compliance capabilities. The platform supports pharmaceutical QC/QA laboratories, biotech R&D laboratories, CDMO testing environments, and clinical diagnostics applications. STARLIMS' multi-industry approach provides pharmaceutical customers with technology validated across multiple regulatory frameworks including ISO 17025, ASCLD-LAB, CALEA, and ISO certifications.

The company was acquired by Abbott in 2009 for $123 million. In July 2021, Abbott sold STARLIMS to private equity firm Francisco Partners.

As a privately-held company under Francisco Partners ownership, current revenue figures and financial metrics are not publicly disclosed. The company has a 35+ year operating history, a 700+ customer base, 2,000+ laboratory deployments globally, and continued investment in product development including Labstep ELN integration and cloud capabilities.

STARLIMS offers an integrated laboratory ecosystem including LIMS (core product), Labstep ELN (electronic laboratory notebook), SDMS (scientific data management system), LES (laboratory execution system), and advanced analytics modules. The platform follows a modular approach allowing customers to implement core LIMS functionality and add additional modules based on laboratory requirements.

The flagship STARLIMS LIMS provides sample management, workflow automation, instrument integration, data integrity controls, electronic signatures, audit trails, and regulatory compliance capabilities. The platform supports web-based access, multi-site deployments, and integration with ERP systems and third-party applications. Recent additions include cloud deployment options and Labstep ELN integration.

STARLIMS maintains technology partnerships for instrument integration, ERP connectivity, and system integration. The platform integrates with laboratory instruments for automated data acquisition, ERP systems for business process integration, and third-party applications via APIs.

The company works with implementation partners and consultants for global deployments. Industry affiliations and accreditation support includes ISO 17025 for laboratory quality management, ASCLD-LAB for forensic laboratories, and CALEA for law enforcement laboratory accreditation. The platform's multi-industry approach requires broad integration capabilities across pharmaceutical, clinical, environmental, and manufacturing laboratory ecosystems.

STARLIMS provides global support and professional services to support 2,000+ laboratories across 85+ countries. Professional services include system implementation, configuration, validation support, data migration, and user training programs. The company offers both direct support and partner-led implementations.

With 270 employees and global customer base, STARLIMS maintains support infrastructure for multi-region deployments. Implementation services address laboratory-specific requirements including instrument integration, workflow configuration, regulatory validation, and legacy system migration. The company has operated for 35+ years across diverse laboratory environments and regulatory frameworks.

STARLIMS holds ISO 9001:2015 quality management certification and ISO 27001:2022 information security certification. The company is led by President & CEO Trey Cook. STARLIMS has 35+ years of industry experience.

G2 rates STARLIMS 4.5/5 across 156 reviews. Capterra rates it 4.4/5 across 16 reviews. STARLIMS holds Leader status on the G2 Momentum Grid.

STARLIMS maintains an active web presence with product information, resources, and demonstration capabilities. The company positions itself as an established enterprise LIMS provider. STARLIMS is reviewed on G2 and Capterra, holds Leader status on the G2 Momentum Grid, and has 35+ years of brand recognition.

STARLIMS has evolved through multiple ownership structures (independent startup → Abbott subsidiary → Francisco Partners portfolio company), maintaining customer relationships and global deployments throughout. STARLIMS competes in the LIMS market through multi-industry capabilities, regulatory compliance breadth, and global deployment scale.